MENU
OGN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Organon & Co (OGN) Earnings Date & Reports

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands... Show more

A.I. Advisor
published Earnings

OGN is expected to report earnings to fall 10.08% to 90 cents per share on February 12

Organon & Co OGN Stock Earnings Reports
Q4'25
Est.
$0.91
Q3'25
Beat
by $0.07
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.11
Q4'24
Missed
by $0.01
The last earnings report on November 10 showed earnings per share of $1.01, beating the estimate of 93 cents. With 6.08M shares outstanding, the current market capitalization sits at 1.98B.
View a ticker or compare two or three
OGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OGN showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
30 Hudson Street
Phone
+1 551 430-6900
Employees
10000
Web
https://www.organon.com